Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Bioanalysis
|
October 4, 2021
Validation of enantioseparation and quantitation of an active metabolite of abrocitinib in human plasma
Sakambari Tripathy, Daria Wentzel, Xia Katty Wan, et al.
Bioanalysis
|
December 21, 2022
Bioanalytical method validation and sample analysis for nirmatrelvir in dried blood collected using the Tasso-M20 device
Katty X Wan, Daniel Potts, Pilar Gonzalez, et al.
Bioanalysis
|
September 5, 2024
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device
Sakambari Tripathy, Katty X Wan, Mohamed H Shahin, et al.
Clinical and Translational Science
|
June 18, 2025
A Pharmacokinetic Study of Zavegepant Nasal Spray in Healthy Adults Comparing Conventional Venous Blood Sampling With Patient-Centric Microsampling
Mohamed H Shahin, Ogert Fisniku, Ding Ding, et al.
Bioanalysis
|
August 16, 2023
Using Mitra sampling to support first-in-human pharmacokinetic evaluations for PF-07059013
Kimberly C Lee, Katty X Wan, Jason Barricklow, et al.
Clinical Pharmacology and Therapeutics
|
August 19, 2023
Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation
Katty Wan, Olga Kavetska, Bharat Damle, et al.
Clinical Pharmacology and Therapeutics
|
June 17, 2022
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment
Sima S Toussi, Joel Michael Neutel, Jesus Navarro, et al.
Clinical and Translational Science
|
September 21, 2022
Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: Promise to reality
Katie F Maass, Matthew D Barfield, Mototsugu Ito, et al.
Bioanalysis
|
May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (<u>Part 1A</u> - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)
Surinder Kaur, Stephen C Alley, Matt Szapacs, et al.
Bioanalysis
|
November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink, Eric Yang, Nicola Hughes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Bioanalysis
|
October 4, 2021
Validation of enantioseparation and quantitation of an active metabolite of abrocitinib in human plasma
Sakambari Tripathy, Daria Wentzel, Xia Katty Wan, et al.
Bioanalysis
|
December 21, 2022
Bioanalytical method validation and sample analysis for nirmatrelvir in dried blood collected using the Tasso-M20 device
Katty X Wan, Daniel Potts, Pilar Gonzalez, et al.
Bioanalysis
|
September 5, 2024
Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device
Sakambari Tripathy, Katty X Wan, Mohamed H Shahin, et al.
Clinical and Translational Science
|
June 18, 2025
A Pharmacokinetic Study of Zavegepant Nasal Spray in Healthy Adults Comparing Conventional Venous Blood Sampling With Patient-Centric Microsampling
Mohamed H Shahin, Ogert Fisniku, Ding Ding, et al.
Bioanalysis
|
August 16, 2023
Using Mitra sampling to support first-in-human pharmacokinetic evaluations for PF-07059013
Kimberly C Lee, Katty X Wan, Jason Barricklow, et al.
Clinical Pharmacology and Therapeutics
|
August 19, 2023
Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation
Katty Wan, Olga Kavetska, Bharat Damle, et al.
Clinical Pharmacology and Therapeutics
|
June 17, 2022
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment
Sima S Toussi, Joel Michael Neutel, Jesus Navarro, et al.
Clinical and Translational Science
|
September 21, 2022
Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: Promise to reality
Katie F Maass, Matthew D Barfield, Mototsugu Ito, et al.
Bioanalysis
|
May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (<u>Part 1A</u> - Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)
Surinder Kaur, Stephen C Alley, Matt Szapacs, et al.
Bioanalysis
|
November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink, Eric Yang, Nicola Hughes, et al.
Page
of 2